Eyal Lifschitz

Neovasc Medical Ltd. develops medical devices for the treatment of refractory angina. It offers minimally invasive treatment for Ischemic heart disease. The company was founded in 2002 by Boaz Lifschitz and is headquartered in Or Yehuda, Israel

Part of Kyocera Corp., Electro-Chemical Research Ltd. is an Israeli company specializing in electronics research and development. The company holds patents for high-capacity storage devices and batteries. The company was founded by Niles A. Fleischer, Eyal Lifschitz.

Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA.

Bio Control Medical BCM Ltd. develops implantable medical devices to treat disorders of the autonomic nervous system. It focuses on the development of the CardioFit System for the treatment of heart failure. The company was founded by Eyal Lifschitz, Yossi Gross and Boaz Lipshitz in 1999 and is headquartered in Yehud, Israel.

Momentis Surgical Ltd. provides robot-assisted surgeries. It offers Hominis, a surgical system with surgical and ergonomics capabilities. The company was founded by Vitaly Vishnepolsky and Nir Shvalb and is headquartered in Or Yehuda, Israel.

Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel.

Part of Venus Medtech (Hangzhou), Inc., Cardiovalve Ltd. is an Israeli medical device company that specializes in developing the Cardiovalve transcatheter system. The company is based in Or Yehuda, Israel. The system is designed to replace regurgitating mitral and tricuspid valves using a transfemoral-transseptal approach. The CEO of the company is Amir Gross. Cardiovalve was acquired by Athena Medtech Holding Ltd. on January 25, 2022 for $83.98 million.

Cordio Medical Ltd. engages in the provision of solutions for monitoring health conditions through speech analysis. The company was founded by Sigal Kremer Tal, Ze'ev Schlik, Shelly Lotan, and Aviv Lotan in 2013 and is headquartered in Or Yehuda, Israel.

Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. It focuses on Neovast Tiara and Neovasc Reducer products. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada.

KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel.